A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Public ClinicalTrials.gov record NCT03970447. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
GBM AGILE: Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent GBM
Study identification
- NCT ID
- NCT03970447
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Global Coalition for Adaptive Research
- Other
- Enrollment
- 2,250 participants
Conditions and interventions
Conditions
Interventions
- ADI-PEG 20 Biological
- AZD1390 Drug
- Lomustine Drug
- Paxalisib Drug
- Radiation Radiation
- Regorafenib Drug
- Temozolomide Drug
- Tinostamustine Drug
- Troriluzole Drug
- VAL-083 Drug
- VT1021 Drug
Biological · Drug · Radiation
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 29, 2019
- Primary completion
- May 31, 2028
- Completion
- May 31, 2030
- Last update posted
- May 7, 2026
2019 – 2030
United States locations
- U.S. sites
- 42
- U.S. states
- 22
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35249 | Recruiting |
| University of California, San Diego | La Jolla | California | 92093 | Recruiting |
| Cedars Sinai - Samuel Oschin Comprehensive Cancer Institute | Los Angeles | California | 90048 | Recruiting |
| University of California, Los Angeles | Los Angeles | California | 90095 | Recruiting |
| St. Joseph Hospital | Orange | California | 92868 | Recruiting |
| University of California, San Francisco | San Francisco | California | 94143 | Recruiting |
| Stanford Cancer Center | Stanford | California | 94305 | Completed |
| University of Colorado Denver | Aurora | Colorado | 80045 | Recruiting |
| Yale Cancer Center / Smilow Cancer Hospital | New Haven | Connecticut | 06511 | Recruiting |
| Mayo Clinic Cancer Center | Jacksonville | Florida | 32224 | Completed |
| Sylvester Comprehensive Cancer Center | Miami | Florida | 33136 | Recruiting |
| Moffitt Cancer Center | Tampa | Florida | 33612 | Recruiting |
| Piedmont Atlanta Hospital | Atlanta | Georgia | 30309 | Recruiting |
| Winship Cancer Institute of Emory University | Atlanta | Georgia | 30322 | Completed |
| LSU Health Sciences Center - New Orleans | New Orleans | Louisiana | 70112 | Active, not recruiting |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | Recruiting |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02115 | Recruiting |
| Henry Ford Health System | Detroit | Michigan | 48202 | Active, not recruiting |
| Allina Health Systems/Abbott Northwestern Hospital | Minneapolis | Minnesota | 55407 | Recruiting |
| Mayo Clinic Cancer Center - Rochester | Rochester | Minnesota | 55905 | Completed |
| University of Mississippi Medical Center | Jackson | Mississippi | 39213 | Completed |
| Washington University School of Medicine - Siteman Cancer Center | St Louis | Missouri | 63110 | Completed |
| Perlmutter Cancer Center, NYU Langone Health | New York | New York | 10016 | Recruiting |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | Recruiting |
| Columbia University Medical Center | New York | New York | 10032 | Recruiting |
| Memorial Sloan Kettering Cancer Center* | New York | New York | 10065 | Recruiting |
| Duke University Medical Center | Durham | North Carolina | 27710 | Recruiting |
| Comprehensive Cancer Center of Wake Forest* | Winston-Salem | North Carolina | 272157 | Recruiting |
| University Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106 | Recruiting |
| Cleveland Clinic | Cleveland | Ohio | 44195 | Recruiting |
| Ohio State University Cancer Center | Columbus | Ohio | 43210 | Recruiting |
| University of Pennsylvania - Perelman Center for Advanced Medicine | Philadelphia | Pennsylvania | 19104 | Recruiting |
| Allegheny General Hospital | Pittsburgh | Pennsylvania | 15212 | Active, not recruiting |
| University of Pittsburgh Medical Center - Hillman Cancer Center | Pittsburgh | Pennsylvania | 15232 | Recruiting |
| Medical University of South Carolina - Hollings Cancer Center | Charleston | South Carolina | 29425 | Recruiting |
| Texas Oncology - Austin | Austin | Texas | 78705 | Active, not recruiting |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | Active, not recruiting |
| University of Texas - MD Anderson Cancer Center | Houston | Texas | 77030 | Recruiting |
| University of Utah - Huntsman Cancer Institute | Salt Lake City | Utah | 84112 | Recruiting |
| University of Virginia Health | Charlottesville | Virginia | 22908 | Recruiting |
| University of Washington Medical Center | Seattle | Washington | 98101 | Active, not recruiting |
| Froedtert Hospital/Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | Active, not recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03970447, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 7, 2026 · Synced May 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03970447 live on ClinicalTrials.gov.